Award
Delivery Order #SPE2DR26FGHL7
Delivery Order for Tamiflu Suspension under Long-Term Pharmaceutical Services Contract
Buyer
Defense Logistics Agency
Award Amount
$465.20
Ceiling
$465.20
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26FGHL7
NAICS
424210
This contract award is a delivery order placed under a pre-existing Indefinite Delivery Vehicle (IDV) contract for pharmaceutical services, secured by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and services. The delivery order entails procuring Tamiflu 6 MG/ML Suspension in 60ml bottles, a critical antiviral medication. This acquisition is significant as it supports sustained healthcare readiness and pharmaceutical supply continuity for the agency. The scope of work is focused on delivering this specific pharmaceutical product within a very short timeframe, ensuring timely availability. The contract follows a competitive bidding process initially established for the IDV, affirming the company's capability to fulfill pharmaceutical needs. The delivery order was awarded recently and is scheduled for performance over a two-day period in early 2026. This award complements the ongoing long-term contract, emphasizing the agency's commitment to maintaining essential medical supplies.
Description
4570867824!TAMIFLU 6 MG/ML SUSPENSION 60ML